Skip to main content
Equibles

MARSHALL WACE, LLP

Position in CDXS — Codexis, Inc.

CIK 1318757 LONDON, X0
Back to CDXS Full portfolio

Position in CDXS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$264,724
+$52,292 QoQ
Shares Held
117,135
+34.5% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 148 holders
Holding Since
Jun 2021
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CDXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. CDXS ranks #237 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 543,897 $270,169,956
2 INCY
Incyte Corp
 1,310,154 $148,519,056
3 RPRX
Royalty Pharma plc
 2,450,669 $137,409,009
4 SYRE
Spyre Therapeutics, Inc.
 991,693 $88,042,503
5 ALNY
Alnylam Pharmaceuticals, Inc.
 259,799 $78,207,292
6 TVTX
Travere Therapeutics, Inc.
 1,333,207 $75,739,488
7 MANE
Veradermics, Inc
 585,560 $71,988,746
8 DFTX
Definium Therapeutics, Inc.
 1,298,946 $61,102,419

All Filings in CDXS

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $264,724 117,135
2025-09-30 $212,432 87,063
2025-06-30 $249,802 102,378
2024-06-30 $89,487 28,867
2022-12-31 $1,646,764 353,383
2022-09-30 $1,876,375 309,633
2022-06-30 $2,870,244 274,402
2022-03-31 $3,130,259 151,807
2021-12-31 $22,321,244 713,823
2021-09-30 $1,850,053 79,538
2021-06-30 $753,354 33,246